Pharmacokinetic-pharmacodynamic modelling of atazanavir in hair among adolescents on antiretroviral treatment in Zimbabwe
Abstract Background Drug potency is a pharmacological parameter defining dose or concentration of drug required to obtain 50% of the drug's maximal effect. Pharmacokinetic-pharmacodynamic modelling and simulation allows estimation of potency and evaluate strategies improving treatment outcome....
Saved in:
Main Authors: | Bernard Ngara (Author), Simbarashe Zvada (Author), Tariro Dianah Chawana (Author), Charles Fungai Brian Nhachi (Author), Simbarashe Rusakaniko (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A population pharmacokinetic model is beneficial in quantifying hair concentrations of ritonavir-boosted atazanavir: a study of HIV-infected Zimbabwean adolescents
by: Bernard Ngara, et al.
Published: (2020) -
Atazanavir–bilirubin interaction: a pharmacokinetic–pharmacodynamic model
by: Lozano R, et al.
Published: (2013) -
Atazanavir–bilirubin interaction: a pharmacokinetic–pharmacodynamic model [Corrigendum]
by: Lozano R, et al.
Published: (2013) -
Should disability-inclusive health be a priority in low-income countries? A case-study from Zimbabwe
by: Hannah Kuper, et al.
Published: (2022) -
Prevalence and factors associated with uptake of pre-exposure prophylaxis amongst women vulnerable to HIV who received HIV antibodies in Antibody Mediated Prevention HVTN703/HPTN081 trial in Harare, Zimbabwe: a cross-sectional study
by: Bernard Ngara, et al.
Published: (2024)